|1.||Silva-Herdade, A S: 1 article (01/2013)|
|2.||Saldanha, C: 1 article (01/2013)|
|3.||Wilcock, G G W: 1 article (01/2004)|
|4.||Birks, J: 1 article (01/2004)|
|5.||Cecchetti, V: 1 article (11/2001)|
|6.||Fravolini, A: 1 article (11/2001)|
|7.||Filipponi, E: 1 article (11/2001)|
|8.||Temperini, A: 1 article (11/2001)|
|9.||Tabarrini, O: 1 article (11/2001)|
|10.||Lamperti, M G: 1 article (11/2001)|
|1.||Alzheimer Disease (Alzheimer's Disease)
09/11/1995 - "Velnacrine produces modest but significant benefits in patients with Alzheimer's disease. "
01/01/1996 - "These data suggest that velnacrine produces modest clinical improvement in a subset of patients with mild-to-severe Alzheimer's disease."
01/01/1996 - "Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. "
01/01/1996 - "Double-blind placebo-controlled study of velnacrine in Alzheimer's disease."
09/01/1992 - "Velnacrine testing for tolerance and safety in both normal elderly subjects and patients with Alzheimer's disease (AD) is reviewed to illustrate the importance of Phase I trials in the target group as more predictive of safety and tolerance for subsequent multicenter trials than those conducted in healthy elderly subjects. "
01/01/1996 - "The present study examines the safety and efficacy of the centrally acting cholinesterase inhibitor, velnacrine, in treating the cognitive symptoms of Alzheimer's disease. "
01/01/1996 - "The present study assessed the safety and efficacy of the cholinesterase inhibitor, velnacrine, for treating the cognitive symptoms of Alzheimer's disease. "
01/01/2004 - "All unconfounded, double-blind, randomized trials in which treatment with velnacrine was administered to patients with dementia of the Alzheimer's type for more than two weeks and its effects compared with those of placebo in a parallel group of patients. "
01/01/2004 - "The trials were identified from a last updated search of the Specialized Register of the Cochrane Dementia and Cognitive Improvement Group on 8 January 2004 using the terms velnacr* and 'HP 029'. "
01/01/2004 - "To determine the clinical efficacy and safety of velnacrine for patients with dementia of Alzheimer's type. "
|4.||Acetylcholine (Acetylcholine Chloride)
|9.||maleic acid (maleate)